Neuroleptic Malignant Syndrome Associated With Metoclopramide
- 1 May 1988
- journal article
- case report
- Published by Southern Medical Association in Southern Medical Journal
- Vol. 81 (5) , 674-5
- https://doi.org/10.1097/00007611-198805000-00035
Abstract
The case of neuroleptic malignant syndrome presented was associated with the use of metoclopramide, a dopamine-blocking agent, which is normally used in nonpsychiatric patients. The patient was successfully treated with dantrolene and bromocriptine. Nonpsychiatrist physicians should be aware of this complication of metoclopramide, as it is potentially fatal.Keywords
This publication has 0 references indexed in Scilit: